Brevetti EPO No.3551189 2023.11.01
Brevetti EPO
(10) Registration Number and Date
2024000023 2024.01.18
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000023 2017.12.08
(40) Publication Number and Date
SM /T/2024/000023 2024.01.18
(30) Priority Details
US 201662432353 P
2016.12.09
US 201762485281 P
2017.04.13
(51) IPC Classes
(71/73) Applicant
(IT) ALEXZA PHARMACEUTICALS, INC. : 2091 Stierlin Ct., Mountain View, CA 94043, US
(72) Inventor
(IT) GONG, Lily : 1411 Montego Drive, San Jose, California 95120, US
(IT) KAMEMOTO, Edwin S. : 585 Dory Lane, Redwood City, California 94065, US
(74) Representative Name
(IT) SANGIACOMO, Ines : Via della Tana, 131, 47890 San Marino RSM, SM
(54) Title
(IT) ALPRAZOLAM PER L’USO NEL TRATTAMENTO DELL’EPILESSIA
(EN) ALPRAZOLAM FOR USE IN TREATING EPILEPSY
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2024.06.28
Event NameDateStatus
Filing2017.12.08Filed
Ricevuta pagamento annualita 72024.01.12Payed
Brevetto EPO concesso2024.01.18Published
Ricevuta pagamento annualita 82024.11.28Payed